Restoration of anti-human immunodeficiency virus type 1 (HIV-1) responses in CD8+ T cells from late-stage patients on prolonged antiretroviral therapy by stimulation in vitro with HIV-1 protein-loaded dendritic cells

Journal of Virology

Volumn 75, Issue 9, 2001, Pages 4413-4419

  Fan, Z ^a   Huang, X L ^a   Borowski, L ^a   Mellors, J W ^a   Rinaldo C R , Jr ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD8 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; INDINAVIR; INTERLEUKIN 12; INTERLEUKIN 2; LAMIVUDINE; LIPOSOME; NELFINAVIR; STAVUDINE; VIRUS PROTEIN; ZIDOVUDINE;

ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEX FORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNOREACTIVITY; IN VITRO STUDY; MULTICENTER STUDY; PRIORITY JOURNAL;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-2; TIME FACTORS; VIRAL PROTEINS;

EID: 0035043482     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.9.4413-4419.2001     Document Type: Article

References (21)

1. Dendritic cells
2. IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro
3. T lymphocyte responses in HIV-1 infection: Implications for vaccine development
4. + T cell immunity
5. Cultured blood dendritic cells retain HIV-1 antigen-presenting capacity for memory CTL during progressive HIV-1 infection
6. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection
7. Photochemical inactivation of viruses with psoralens: An overview
8. Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses
9. + T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects
10. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus
11. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy
12. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics
13. A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 ligand and interferon-gamma treatment
14. Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: Correlation with disease progression
15. HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy
16. Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy
17. + T cell numbers in progression of HIV-1 infection
18. + T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency
19. Antigen capture, processing, and presentation by dendritic cells: Recent cell biological studies
20. Proinflammatory and immunoregulatory functions of interleukin-12
21. Delivery of liposome-encapsulated HIV type 1 proteins to human dendritic cells for stimulation of HIV type 1-specific memory cytotoxic T lymphocyte responses